Ticker brief
EPRX EUPRAXIA PHARMACEUTICALS INC
Consumer, Non-cyclical · Biotechnology
last close
$6.69
1 day
-0.3%
14 days
+3.2%
mkt cap
·
signals 14d
6
authors 14d
3
Sentiment — last 14 days
daily mean sentiment, 2026-06-21 → 2026-07-01 · now +0.10 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @VistaPResearch | C | · | 3 | +0.28 |
| @Gantosj | B | -0.80 | 2 | +0.00 |
| @Quantumup1 | C | -1.95 | 1 | +0.55 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-01 | @VistaPResearch | +0.20 | Daily market headline says listed tickers rise. | -0.3% | tweet ↗ |
| 2026-07-01 | @Gantosj | +0.00 | Watches how Canadian stocks trade in the US while TSX is closed. | -0.3% | tweet ↗ |
| 2026-06-30 | @VistaPResearch | +0.20 | Market recap says AI supercycle mainstream and listed names rise. | +1.2% | tweet ↗ |
| 2026-06-29 | @Gantosj | +0.00 | lists Canadian tickers affected by market holiday trading schedule | +1.5% | tweet ↗ |
| 2026-06-25 | @Quantumup1 | +0.55 | Oppenheimer initiated EPRX at Outperform with $17 target. | +4.4% | tweet ↗ |
| 2026-06-21 | @VistaPResearch | +0.45 | Says Sanofi and Eupraxia belong on every immunology watchlist. | +3.2% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.